Trending News
News
News
DSM Biologics and Crucell Announce Licensing Agreement with Medarex
This license agreement allows Medarex to use the PER.C6® production platform in its antibody research.
News
Millipore Corporation and Novozymes Form Strategic Alliance to Supply Animal-Free Cell Culture Supplements for Bioprocessing
Alliance will accelerate launch of new animal-free supplements and provide customers with a source of high performance cell culture products.
News
BD Acquires Right to Negotiate Business Relationship for Accelr8’s BACcel® Technology
Becton Dickinson has purchased an exclusive right to negotiate for a business relationship to develop Accelr8’s BACcel® rapid diagnostic platform.
News
Cancer Cell Line Developed that is Resistant to new Cancer Therapy
Researchers found the HDAC inhibitor-resistant cell line resistant to many therapies but highly sensitive to heat shock protein 90 inhibitors, another emerging cancer treatment.
News
ImmunoVaccine Technologies to Acquire Immunotope
The acquisition will bring together IVT's signature VacciMax® platform with Immunotope's portfolio of immunotherapeutic antigens and antigen discovery platform.
News
The Closest Look Ever at Native Human Tissue
EMBL researchers have published the first 3D image of human skin at molecular resolution and reveal the molecular Velcro-like organization that interlinks cells.
News
Beckman Coulter Collaborates in Multisite Research Project for Cardiovascular Disease Markers
The collaborative research will seek to discover genetic signatures for cardiovascular disease and obesity-related hypertension.
News
BioSeek Initiates Systems Biology Compound Evaluation Collaboration with UCB
BioSeek will apply its BioMAP® systems to evaluate a number of UCB compounds across several target classes.
News
AVEO Pharmaceuticals and Lilly Sign Collaboration for Clinical Drug Response Project
Agreement highlights growing interest in novel biology platform that identifies clinical response of cancer drugs.
News
Buck Institute and Neurobiological Technologies Partner to Develop Treatment for Huntington's Disease
The research involves fibroblast growth factor-2 (FGF-2), a naturally occurring protein that has been studied extensively for its neuroprotective properties.
Advertisement